Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients
Authors:
- 1 August 2011
- journal article
- clinical trial
- Published by S. Karger AG in Oncology
- Vol. 80 (5-6) , 366-372
Abstract
Advanced chronic hepatitis C patients with sustained virolological response by antivirals remain at risk for hepatocellular carcinoma (HCC). We investigated the incidence of HCC during and immediately after peginterferon-alfa-2a and ribavirin (RBV) treatment in patients with chronic hepatitis C in Japan. HCC was detected in 8 of 238 patients during and after these treatments (mean follow-up period: 572 ± 252 days). In conclusion, occurrence of HCC is not a rare event during and immediately after peginterferon-alfa-2a plus RBV treatment. In cases with cirrhosis, higher α-fetoprotein levels, old age, or a previous history of HCC treatment, clinicians should be especially alert for the possible development of HCC during and immediately after peginterferon-alfa-2a and RBV treatment. Clinicians should regularly check for the possible development of HCC even in chronic hepatitis C patients under treatment.Keywords
This publication has 25 references indexed in Scilit:
- Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta‐analysis of randomized controlled trialsInternational Journal of Cancer, 2011
- Editorial : Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward TreatmentAmerican Journal of Gastroenterology, 2010
- Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶Hepatology, 2010
- New antiviral therapies for chronic hepatitis CHepatology International, 2010
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosisJournal of Hepatology, 2010
- Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related CirrhosisClinical Gastroenterology and Hepatology, 2010
- State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus XCancer Letters, 2006
- Trends in health care resource use for hepatitis C virus infection in the United States†Hepatology, 2005
- Favorable Prognosis of Chronic Hepatitis C After Interferon Therapy by Long–Term Cohort StudyHepatology, 2003
- Hepatitis C and hepatocellular carcinomaHepatology, 1997